The Trump administration unveiled an outline for potentially lowering the price of prescription drugs.
The blueprint identifies four key areas of focus:
1. Improved competition
2. Better negotiation
3. Incentives for lower list prices
4. Lowering out-of-pocket costs
Stay tuned for updates later in the year. Read More